冠状病毒病2019在慢性肾脏疾病:一个病例报告

Dela Hangri Jalmas, Fauzar Fauzar, Roza Kurniati, Deka Viotra, Harnavi Harun, Vesri Yoga, Alexander Kam
{"title":"冠状病毒病2019在慢性肾脏疾病:一个病例报告","authors":"Dela Hangri Jalmas, Fauzar Fauzar, Roza Kurniati, Deka Viotra, Harnavi Harun, Vesri Yoga, Alexander Kam","doi":"10.25077/JKA.V10I2.1718","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has caused substantial morbidity and mortality worldwide. Older patients, male gender and those with preexisting comorbidities such as chronic kidney disease are reported to be more likely infected with SARS CoV-2 and are at higher risk of severe illness or death. It has been reported a 24 years old male was admitted to the hospital with shortness of breath, coughing, fever and paleness. The history of contact with confirmed COVID-19 cases was unclear. The patient works as a security officer. A history of hypertension is present. Laboratory results showed hemoglobin 7 g/dl, ureum 261 mg/dl, and creatinine 22,9 mg/dl. On the second day of admission, the patient experience increased shortness of breath, decreased consciousness and epistaxis. From the result of the nasopharyngeal swab, the patient tested positive for COVID-19 and was given Oseltamivir 75mg. The patient is prepared for hemodialysis, which was performed in the isolation room. After hemodialysis, the patient's condition improved with decreased shortness of breath and increased of consciousness. The patient comes out from the isolation room and discharges home in good condition. Antiviral therapy in CKD patients with Covid-19 infection requires dose adjustment. Immediate hemodialysis is required in patients with CKD and coexisting COVID-19 infection to improve the patient's condition. Prompt management for patients with CKD and COVID-19 will reduce the risk of mortality.Keywords:  COVID-19, chronic kidney disease, hemodialysis","PeriodicalId":30736,"journal":{"name":"Jurnal Kesehatan Andalas","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Coronavirus Disease 2019 in Chronic Kidney Disease: A Case Report\",\"authors\":\"Dela Hangri Jalmas, Fauzar Fauzar, Roza Kurniati, Deka Viotra, Harnavi Harun, Vesri Yoga, Alexander Kam\",\"doi\":\"10.25077/JKA.V10I2.1718\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The COVID-19 pandemic has caused substantial morbidity and mortality worldwide. Older patients, male gender and those with preexisting comorbidities such as chronic kidney disease are reported to be more likely infected with SARS CoV-2 and are at higher risk of severe illness or death. It has been reported a 24 years old male was admitted to the hospital with shortness of breath, coughing, fever and paleness. The history of contact with confirmed COVID-19 cases was unclear. The patient works as a security officer. A history of hypertension is present. Laboratory results showed hemoglobin 7 g/dl, ureum 261 mg/dl, and creatinine 22,9 mg/dl. On the second day of admission, the patient experience increased shortness of breath, decreased consciousness and epistaxis. From the result of the nasopharyngeal swab, the patient tested positive for COVID-19 and was given Oseltamivir 75mg. The patient is prepared for hemodialysis, which was performed in the isolation room. After hemodialysis, the patient's condition improved with decreased shortness of breath and increased of consciousness. The patient comes out from the isolation room and discharges home in good condition. Antiviral therapy in CKD patients with Covid-19 infection requires dose adjustment. Immediate hemodialysis is required in patients with CKD and coexisting COVID-19 infection to improve the patient's condition. Prompt management for patients with CKD and COVID-19 will reduce the risk of mortality.Keywords:  COVID-19, chronic kidney disease, hemodialysis\",\"PeriodicalId\":30736,\"journal\":{\"name\":\"Jurnal Kesehatan Andalas\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Kesehatan Andalas\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25077/JKA.V10I2.1718\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Kesehatan Andalas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25077/JKA.V10I2.1718","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

新冠肺炎大流行在全球范围内造成了大量的发病率和死亡率。据报道,年龄较大的患者、男性和患有慢性肾脏病等合并症的患者更有可能感染严重急性呼吸系统综合征冠状病毒2型,患重症或死亡的风险更高。据报道,一名24岁男性因呼吸急促、咳嗽、发烧和面色苍白入院。与新冠肺炎确诊病例的接触史尚不清楚。病人是一名保安。有高血压病史。实验室结果显示血红蛋白7 g/dl,尿素261 mg/dl,肌酐22.9 mg/dl。入院第二天,患者出现呼吸急促、意识下降和鼻出血症状。根据鼻咽拭子检测结果,该患者新冠肺炎检测呈阳性,并服用75毫克奥司他韦。患者准备在隔离室进行血液透析。血液透析后,患者的情况有所改善,呼吸急促减少,意识增强。病人从隔离室出来,出院回家,情况良好。新冠肺炎感染CKD患者的抗病毒治疗需要调整剂量。CKD和合并感染新冠肺炎的患者需要立即进行血液透析,以改善患者的病情。及时管理CKD和新冠肺炎患者将降低死亡率。关键词:新冠肺炎、慢性肾脏病、血液透析
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Coronavirus Disease 2019 in Chronic Kidney Disease: A Case Report
The COVID-19 pandemic has caused substantial morbidity and mortality worldwide. Older patients, male gender and those with preexisting comorbidities such as chronic kidney disease are reported to be more likely infected with SARS CoV-2 and are at higher risk of severe illness or death. It has been reported a 24 years old male was admitted to the hospital with shortness of breath, coughing, fever and paleness. The history of contact with confirmed COVID-19 cases was unclear. The patient works as a security officer. A history of hypertension is present. Laboratory results showed hemoglobin 7 g/dl, ureum 261 mg/dl, and creatinine 22,9 mg/dl. On the second day of admission, the patient experience increased shortness of breath, decreased consciousness and epistaxis. From the result of the nasopharyngeal swab, the patient tested positive for COVID-19 and was given Oseltamivir 75mg. The patient is prepared for hemodialysis, which was performed in the isolation room. After hemodialysis, the patient's condition improved with decreased shortness of breath and increased of consciousness. The patient comes out from the isolation room and discharges home in good condition. Antiviral therapy in CKD patients with Covid-19 infection requires dose adjustment. Immediate hemodialysis is required in patients with CKD and coexisting COVID-19 infection to improve the patient's condition. Prompt management for patients with CKD and COVID-19 will reduce the risk of mortality.Keywords:  COVID-19, chronic kidney disease, hemodialysis
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
25
审稿时长
24 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信